Expansion catalysts GenePlanet is rapidly expanding its geographic footprint with recent acquisitions in Hungary and broader European growth, presenting opportunities to cross-sell partnerships with newly integrated labs and to tailor enterprise testing contracts for multi-country healthcare providers.

Strategic funding Significant recent and ongoing funding rounds from notable investors (Darwin AG, BlackPeak Capital, Lauxera) signal strong growth trajectory and validation, suggesting potential for upsell of high-volume testing solutions, premium data services, and collaboration on R&D projects.

Laboratory scale With a centralized lab historically based in Zagreb and new acquisitions, there is a clear path to offer scalable NIPT and lifestyle/genetic testing services to large medical centers, insurers, and corporate health programs seeking standardized, wide-area genetic testing.

Digital enablement GenePlanet utilizes a modern tech stack (Azure, Docker, Kubernetes, data analytics tools) and digital marketing channels, indicating readiness for integrated customer portals, automated order processing, and secure data exchange partnerships with clinics and insurers.

Clinical partnerships Longstanding collaboration with over 1000 medical centers and doctors positions GenePlanet for co-branding or exclusive tests with healthcare providers, enabling targeted sales of NIPT, cancer screening, and lifestyle DNA offerings to priority accounts.